Cargando…

Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures

Background: Activated Clotting Time (ACT) guided heparinization is the gold standard for titrating unfractionated heparin (UFH) administration during atrial fibrillation (AF) ablation procedures. The current ACT target (300 s) is based on studies in patients receiving a vitamin K antagonist (VKA). S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benali, Karim, Verain, Julien, Hammache, Nefissa, Guenancia, Charles, Hooks, Darren, Magnin-Poull, Isabelle, Toussaint-Hacquard, Marie, de Chillou, Christian, Sellal, Jean-Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465849/ https://www.ncbi.nlm.nih.gov/pubmed/34575348 http://dx.doi.org/10.3390/jcm10184240

Ejemplares similares

Efficacy and Safety of Second and Third-Generation Laser Balloon for Paroxysmal Atrial Fibrillation Ablation Compared to Radiofrequency Ablation: A Matched-Cohort
por: Guenancia, Charles, et al.
Publicado: (2021)

How to use pace mapping for ventricular tachycardia ablation in postinfarct patients
por: Guenancia, Charles, et al.
Publicado: (2022)

Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation?
por: Hammache, Néfissa, et al.
Publicado: (2021)

New Perspective in Atrial Fibrillation
por: Sagnard, Audrey, et al.
Publicado: (2020)

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study
por: Badoz, Marc, et al.
Publicado: (2021)

Smoking and Activated Clotting Time during coronary angiography and angioplasty: protocol for the ACT-Tobacco trial
por: Trimolé, Régis, et al.
Publicado: (2023)

Atrial fibrillation in patients with cardiac amyloidosis and heart failure: a desperate cause?
por: Sellal, Jean-Marc, et al.
Publicado: (2023)

Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter?
por: Martin, Anne-Céline, et al.
Publicado: (2020)

A New Danger to the Race
Publicado: (1883)

The Twilight Sleep Propaganda: A Danger to the Race
Publicado: (1916)

The Danger of Badly-Made and Old Catheters
Publicado: (1873)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Anticoagulants and Immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
por: Turi, S, et al.
Publicado: (2020)

Nanodroplet-mediated catheter-directed sonothrombolysis of retracted blood clots
por: Goel, Leela, et al.
Publicado: (2021)

Effects of anticoagulation on markers of activation of clotting following major orthopedic surgery
por: Bern, M M, et al.
Publicado: (2015)

Clot accumulation at the tip of hemodialysis catheters in a large animal model
por: Tal, Michael G., et al.
Publicado: (2020)

Clot in Transit: Therapy via Peripherally Inserted Central Catheter Line
por: Mustafa, Ala, et al.
Publicado: (2022)

The Danger of Deterioration of Race from the Too Rapid Increase of Great Cities
Publicado: (1867)

Relationship between Exercise Intensity and IL-6 Increase during an 80 km Long-Distance Running Race
por: Jouffroy, Romain, et al.
Publicado: (2022)

To Clot or Not to Clot: Is That the Question?
por: Favaloro, Emmanuel J.
Publicado: (2023)

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
por: Lau, Yee Cheng, et al.
Publicado: (2016)

Fragmentation of airway tube exchange catheter: A dangerous situation
por: Swaro, Swastika, et al.
Publicado: (2023)

Four danger response programs determine glomerular and tubulointerstitial kidney pathology: Clotting, inflammation, epithelial and mesenchymal healing
por: Anders, Hans-Joachim
Publicado: (2012)

Stroke thrombectomy catheter for aspiration of refractory or inaccessible clot in acute myocardial infarction
por: Klaudel, Jacek, et al.
Publicado: (2022)

When Clot Is Tumor: A Roadmap to Anticoagulation in Renal Cell Carcinoma With Tumor Thrombus
por: Hsu, Miles, et al.
Publicado: (2022)

Emotions run high in race for collider
por: Cartlidge, E
Publicado: (2001)

Non vitamin K anticoagulation drugs will win the race
por: Van Gelder, I. C., et al.
Publicado: (2016)

Atrioesophageal Fistula: A Rare but Dangerous Complication From Catheter Ablation
por: Ventre, Scott, et al.
Publicado: (2023)

Honey Bee Venom (Apis mellifera) Contains Anticoagulation Factors and Increases the Blood-clotting Time
por: Zolfagharian, Hossein, et al.
Publicado: (2015)

Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Clot or Not?
por: Peretz-Larochelle, Maude, et al.
Publicado: (2018)

Clot Retention: Our Experiences with a Simple New Technique of Evacuation with a Thoracic Catheter
por: Aydin, Cemil, et al.
Publicado: (2019)

Slippery liquid infused fluoropolymer coating for central lines to reduce catheter associated clotting and infections
por: Bandyopadhyay, Saibal, et al.
Publicado: (2020)

Direct thromboaspiration efficacy for mechanical thrombectomy is related to the angle of interaction between the aspiration catheter and the clot
por: Bernava, Gianmarco, et al.
Publicado: (2020)

Retrieval of a tracheobronchial blood clot with a Yankauer suction catheter in complete airway obstruction
por: Kaushik, Sharad, et al.
Publicado: (2021)

Experimental evaluation of direct thromboaspiration efficacy according to the angle of interaction between the aspiration catheter and the clot
por: Bernava, Gianmarco, et al.
Publicado: (2021)

Inexpensive and combined technique: Use of suction tracheal catheter and hydrogen peroxide for the evacuation of intravesical clots
por: Montelongo-Rodríguez, Fred Alain, et al.
Publicado: (2022)

Use of activated clotting time to monitor anticoagulation in patients receiving unfractionated heparin on renal replacement therapy
por: Bidwai, A, et al.
Publicado: (2011)

The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study
por: Nishimoto, Yuji, et al.
Publicado: (2022)

Fibrin clot characteristics and anticoagulant response in a SARS‐CoV‐2‐infected endothelial model
por: McCafferty, Conor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mtjlo76ms0iph0jpfchrr7n6jm